Tolak is owned by Hill Dermaceuticals.
Tolak contains Fluorouracil.
Tolak has a total of 1 drug patent out of which 0 drug patents have expired.
Tolak was authorised for market use on 18 September, 2015.
Tolak is available in cream;topical dosage forms.
The generics of Tolak are possible to be released after 18 July, 2023.
|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US7169401||HILL DERMACEUTICALS||Topical skin care composition containing refined peanut oil|| |
(3 months from now)
Drugs and Companies using FLUOROURACIL ingredient
Market Authorisation Date: 18 September, 2015
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic